Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
'Major friction' : Trump challenged by 10 GOP senators in school funds fight back
17/07/2025
'He's just mad' : GOP leader pressures Mike Johnson as speaker faces 'brutal' day
17/07/2025
This gangster move is just Trump's latest disgrace
17/07/2025
'We asked and we asked' : GOP 'stonewalled' on details of massive cuts
17/07/2025
GOP lawmaker puts Trump on notice that he may 'lose the majority this midterm'
17/07/2025
'Trump is in denial' : Ex-senator says president's own 'monster' eating him alive
17/07/2025
